...
首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Utility of a 0.035″ compatible rapid-exchange balloon (Metacross RX?) as a perfusion balloon in endovascular therapy compared with conventional percutaneous coronary intervention: A mini-review
【24h】

Utility of a 0.035″ compatible rapid-exchange balloon (Metacross RX?) as a perfusion balloon in endovascular therapy compared with conventional percutaneous coronary intervention: A mini-review

机译:0.035“兼容的快速交换气球(Metacross Rx?)作为血管疗法的灌注球囊的效用与常规经皮冠状动脉干预相比:迷你审查

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Since endovascular treatment for peripheral artery disease has been rapidly and widely adopted as the preferred strategy, interventionists sometimes experience complications such as vessel perforation and severe dissections. We have a long-time inflation strategy for perfusion balloon catheters, which could be a solution for vessel complications in coronary sections, but not in peripheral sections. We invented a simple device for application as a perfusion balloon in peripheral sections, using a 0.035″ wire compatible rapid-exchange balloon Metacross RX? (TERUMO, Tokyo, Japan) and reviewed this strategy using three cases as examples and compared them with the coronary perfusion balloon. Table of contents summary Metacross RX (TERUMO, Tokyo, Japan) is being used as a rapid exchange balloon and can be potentially used as a perfusion balloon. We report a series of cases in which patients were treated using the Metacross RX at a single-center for endovascular treatment of peripheral artery disease. We review and discuss the use of this device in comparison with the conventional coronary perfusion balloon catheter. Highlights ? No perfusion balloon catheters exist in endovascular treatment section. ? The 0035″ compatible rapid-exchange balloon could be a perfusion balloon. ? The gap between the wire lumen and the 0.014″ wire is a key point. ? Three cases were reviewed compared with percutaneous coronary intervention.
机译:发明内容由于外周枢动疾病的血管内治疗已被迅速和广泛采用作为优选的策略,介入者有时会经历血管穿孔和严重剖析等并发症。我们对灌注球囊导管具有长期通胀策略,这可能是冠状动脉切片中血管并发症的溶液,但不在外围部分。我们发明了一种简单的应用程序,用于在外围部分中作为灌注球囊,使用0.035“导线兼容的快速交换气球Metacross Rx? (Terumo,Terkyo,Japan)并使用三种案例作为示例进行审查的策略,并将其与冠状动脉灌注球囊进行比较。目录摘要Metacross RX(Terumo,Tokkyo,日本)被用作快速交换气球,并且可能被用作灌注气球。我们报告了一系列案例,其中使用Metacross Rx治疗患者的外周动脉疾病的血管内治疗。我们审查并讨论了与传统的冠状动脉灌注球囊导管相比使用该装置。强调 ?血管内处理部分中没有存在灌注球囊导管。还0035“兼容的快速交换气球可能是灌注球囊。还电线腔和0.014“线之间的间隙是关键点。还与经皮冠状动脉干预相比,审查了三种病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号